CTRI/2022/06/043236招募中3 期
Efficacy of dapafliflozin in diabetic peripheral neuropathy, a randomized controlled trial - DINE
Postgraduate Institute of Medical Education Research0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 3 期
- 状态
- 招募中
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1.Type 2 Diabetes Mellitus 5-10 years duration
- •2.Age 18yrs- 75 yrs
- •3.Presence of neuropathy at baseline (MNSI score >4 )
- •4.eGFR > 30ml/min/m2
- •5.HBA1c between 7-10
排除标准
- •1.Untreated Hypothyroidism
- •2.Patients currently on SGLT2 inhibitors
- •3.History of Leprosy
- •4.Patients with current foot ulcer
- •5.Presence of Peripheral Vascular disease with critical limb ischemia (ABI <0.7 )
- •6.History of alcoholism ( >2 and >1 standard drink per day for male and female respectively)
- •7.Factors affecting corneal nerves (severe dry eyes, severe corneal dystrophies, ocular trauma or surgery in the preceding 6 months)
- •Negative consent
研究者
相似试验
Unknown
2 期
Efficacy of Dapagliflozin in Diabetes Associated Peripheral NeuropathyDiabetic Peripheral NeuropathyNCT05162690Post Graduate Institute of Medical Education and Research, Chandigarh40
尚未招募
4 期
Dapagliflozin in Acute Heart failureIRCT20220529055013N1Public Sector medical University160
已完成
不适用
The potential effect of Dapagliflozin on diabetic macular edemadiabetic macular edema, diabetesJPRN-UMIN000020331Kyoto Prefectural University of Medicine Department of Endocrinology and Metabolism45
招募中
1 期
Dapaglifozin use in patients with heart failure during acute myocardial infarctioEUCTR2021-002813-33-ITAZIENDA OSPEDALIERO UNIVERSITARIA MAGGIORE DELLA CARITà DI NOVARA140
尚未招募
不适用
Effect of Dapagliflozin for type 2 diabetes mellitus with fatty liverJPRN-UMIN000026549Kagawa prefectural central hospital25